logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Nungruthai Suntronwong

chulalongkorn university
H指数:21
被引数:1,827

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Achieving Hepatitis C Micro-Elimination in a High-Burden Province of Thailand: The Phetchabun Model

在泰国高负担省份实现丙型肝炎微型消除：彭世郭模式

Tropical Medicine and Infectious Disease
IF2.6
2026-08-020
OA
Wijitra Phaengkha; Pornjarim Nilyanimit; Nungruthai Suntronwong; Jiratchaya Puenpa; Duong Hoang Huy Le; Saranya Ngamnimit; Pattama Janpathip; Lapasrada Kamput; Kawin Thongnoi; Wanalee Toomta; Phatcha Wohanklong; Jarunlak Saokeaw; Niphapornt Thammajit; Suwannee Rerngleum; Ananyalak Yoisara; Nitiya Srisuk; Jidapa Suwannachat; Anchalee Karagate; Rujipat Wasitthankasem; Yong Poovorawan
Significant reduction in Hepatitis B virus infections following 32 years of universal Hepatitis B vaccination as part of EPI, Thailand

乙型肝炎病毒感染显著减少后32年的普遍乙肝疫苗接种作为EPI的一部分，泰国

SCIENTIFIC REPORTS
IF3.9
2025-01-070
OAAI
Nilyanimit, Pornjarim; Wanlapakorn, Nasamon; Vichaiwattana, Preeyaporn; Wongsrisang, Lakkhana; Klinfueng, Sirapa; Suntronwong, Nungruthai; Bhunyakitikorn, Wichan; Angsuwatcharakon, Piyada; Sonthichai, Chaninan; Thawinwisan, Narong; Puedkuntod, Pichet; Phattharasrivongchai, Sunsanee; Loprakhon, Parichaya; Tinnaitorn, Watcharanan; Luankaew, Thawatchai; Vinothai, Sasithorn; Chaijaroen, Somjet; Meechin, Pornsawan; Pongpichit, Chalermpol; Poovorawan, Yong
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection
VACCINES
IF3.4
2024-02-102
OAAI
Suntronwong, Nungruthai; Kanokudom, Sitthichai; Auphimai, Chompoonut; Thongmee, Thanunrat; Assawakosri, Suvichada; Vichaiwattana, Preeyaporn; Yorsaeng, Ritthideach; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Nilyanimit, Pornjarim; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Poovorawan, Yong
Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3-4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination

异源新型冠状病毒肺炎加强疫苗在健康成人中接种两剂CoronaVac疫苗后3-4个月对Omicron BA.1，BA.2和BA.4/5变体的免疫原性和持久性

HELIYON
IF3.6
2024-01-011
OAAI
Assawakosri, Suvichada; Kanokudom, Sitthichai; Suntronwong, Nungruthai; Chansaenroj, Jira; Auphimai, Chompoonut; Nilyanimit, Pornjarim; Vichaiwattana, Preeyaporn; Thongmee, Thanunrat; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Klinfueng, Sirapa; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Mongkolsapaya, Juthathip; Honsawek, Sittisak; Poovorawan, Yong
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023
SCIENTIFIC REPORTS
IF3.9
2023-09-2010
OAAI
Chansaenroj, Jira; Suntronwong, Nungruthai; Kanokudom, Sitthichai; Assawakosri, Suvichada; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Wongsrisang, Lakana; Thongmee, Thanunrat; Aeemjinda, Ratchadawan; Khanarat, Nongkanok; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Yorsaeng, Ritthideach; Katanyutanon, Apirat; Thanasopon, Wichai; Bhunyakitikorn, Wichan; Sonthichai, Chaninan; Angsuwatcharakorn, Piyada; Withaksabut, Withak; Wanlapakorn, Nasamon; Sudhinaraset, Natthinee; Poovorawan, Yong
SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis

新型冠状病毒肺炎疫苗接种和感染后的SARS-CoV-2抗体动态: 真实世界横断面分析

VACCINES
IF3.4
2023-06-308
OAAI
Yorsaeng, Ritthideach; Atsawawaranunt, Kamolthip; Suntronwong, Nungruthai; Kanokudom, Sitthichai; Chansaenroj, Jira; Assawakosri, Suvichada; Nilyanimit, Pornjarim; Aeemjinda, Ratchadawan; Khanarat, Nongkanok; Wongsrisang, Lakkhana; Auphimai, Chompoonut; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Thongmee, Thanunrat; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Poovorawan, Yong
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years
JOURNAL OF MEDICAL VIROLOGY
IF4.6
2023-04-273
PRE
Wanlapakorn, Nasamon; Kanokudom, Sitthichai; Phowatthanasathian, Harit; Chansaenroj, Jira; Suntronwong, Nungruthai; Assawakosri, Suvichada; Yorsaeng, Ritthideach; Nilyanimit, Pornjarim; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Thongmee, Thanunrat; Aeemjinda, Ratchadawan; Khanarat, Nongkanok; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Chantima, Warangkana; Pakchotanon, Pattarakul; Duangchinda, Thaneeya; Sudhinaraset, Natthinee; Poovorawan, Yong
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5

12种不同的三剂量方案后的第四剂mRNA新型冠状病毒肺炎疫苗: 对Omicron BA.4/BA.5的安全性和免疫原性

VACCINES
IF3.4
2023-03-016
OAAI
Kanokudom, Sitthichai; Chansaenroj, Jira; Suntronwong, Nungruthai; Assawakosri, Suvichada; Yorsaeng, Ritthideach; Nilyanimit, Pornjarim; Aeemjinda, Ratchadawan; Khanarat, Nongkanok; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Thongmee, Thanunrat; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Honsawek, Sittisak; Poovorawan, Yong
Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study
ECLINICALMEDICINE
IF10
2022-10-018
OAAI
Teeyapun, Nattaya; Luangdilok, Sutima; Pakvisal, Nussara; Sainamthip, Panot; Mingmalairak, Siyamol; Poovorawan, Nattaya; Sitthideatphaiboon, Piyada; Parinyanitikul, Napa; Sriuranpong, Virote; Namkanisorn, Teerayuth; Inthasuwan, Pratchaya; Angspatt, Pattama; Wongchanapat, Ploytuangporn; Bamrungnam, Akradach; Leeleakpai, Nutchanok; Uttha, Sutheera; Jaichum, Supaporn; Kongkaew, Peerawich; Suksanong, Chayanin; Veranitinun, Rattiya; Prasomphol, Ampai; Sartsuk, Chada; Patcharajutanon, Cheeraporn; Preaprang, Supreeya; Choengsamor, Hathairat; Phongwan, Rungthong; Preeyasaksa, Charoenpit; Phaibulvatanapong, Ekkamol; Suntronwong, Nungruthai; Yorsaeng, Ritthideach; Vichaiwattana, Preeyaporn; Wanlapakorn, Nasamon; Kerr, Stephen J.; Poovorawan, Yong; Wanchaijiraboon, Passakorn; Tanasanvimon, Suebpong
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine

先前接受过初级异源CoronaVac/ChAdOx1疫苗的实体癌患者第三次新型冠状病毒肺炎mRNA加强后的免疫原性

VACCINES
IF3.4
2022-09-268
OAAI
Luangdilok, Sutima; Wanchaijiraboon, Passakorn; Pakvisal, Nussara; Susiriwatananont, Thiti; Zungsontiporn, Nicha; Sriuranpong, Virote; Sainamthip, Panot; Suntronwong, Nungruthai; Vichaiwattana, Preeyaporn; Wanlapakorn, Nasamon; Poovorawan, Yong; Teeyapun, Nattaya; Tanasanvimon, Suebpong
Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination

异源CoronaVac/AZD1222疫苗接种后，增强mRNA和腺病毒载体疫苗对omicron BA.1和BA.2免疫反应的影响

JOURNAL OF MEDICAL VIROLOGY
IF4.6
2022-08-1018
OA
Suntronwong, Nungruthai; Kanokudom, Sitthichai; Auphimai, Chompoonut; Assawakosri, Suvichada; Thongmee, Thanunrat; Vichaiwattana, Preeyaporn; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Chansaenroj, Jira; Puenpa, Jiratchaya; Nilyanimit, Pornjarim; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Mongkolsapaya, Juthathip; Poovorawan, Yong

研究方向

暂未获取到该数据
Y
Yong Poovorawan
H 指数:64论文数:977被引数:2.2万
N
Nasamon Wanlapakorn
H 指数:29论文数:173被引数:2,900
P
Preeyaporn Vichaiwattana
H 指数:24论文数:112被引数:1,696
S
Sitthichai Kanokudom
H 指数:15论文数:64被引数:788
T
Thanunrat Thongmee
H 指数:22论文数:94被引数:1,486
S
Suvichada Assawakosri
H 指数:15论文数:48被引数:709
R
Ritthideach Yorsaeng
H 指数:20论文数:76被引数:1,194
P
Pornjarim Nilyanimit
H 指数:15论文数:73被引数:775
S
Sirapa Klinfueng
H 指数:20论文数:84被引数:1,198
N
Natthinee Sudhinaraset
H 指数:18论文数:63被引数:912